Glycobiology Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI4111
Glycobiology Market size is projected to experience significant growth from 2019 to 2025.
Growing investments from government have allowed academic researchers to develop new glycomics and glycobiology tools. Major biotech and pharmaceutical companies are also investing profoundly into the research and development of biological products such as products related to proteomics and glycobiology products. Hence, growing investments is one of the major factors contributing to the growth of the market.
Technological advancements have also contributed towards the growth of glycobiology market owing to increased demand for glycomics instruments. Various procedures including protein characterizations are developing into advanced technologies such as mass spectrometry, high performance liquid chromatography and capillary electrophoresis in biochemical and chemical research. These advanced techniques offer rapid and highly sensitive results which has further propelled the growth of the market.
The growing demand for glycoprotein-based drugs as therapeutics against inflammatory disease and cancer have further witness the significant growth in biotechnology industry that in turn has propelled the growth of the market. The ongoing trend to combine the entire glycomic and glycoproteomic analytical platforms into a microchip format has further contributed to the growth of the market.
However, stringent regulatory frameworks and time-consuming approval processes along with high degree of consolidation may impede the growth of glycobiology market.
Instruments segment is witnessing a significant growth in the market. This is attributed to the frequent usage of diagnostic testing and drug discovery. The purchase of kits and reagents frequently is another factor contributing to the growth of the segment.
Drug discovery and development segment is expected to witness the lucrative growth over the forecast period. This is attributed to intense research and significant funding by government for research related projects for glycomics.
Academic and research institutes is expected to witness lucrative growth over the forecast period. Collaborations between major organizations and research institutes are further propelling the growth of the market.
North America glycobiology market is dominating the market due to the large presence of biotechnology and pharmaceutical companies. Presence of well-established healthcare infrastructure and accessibility to the advanced products have further driven the growth of market in the region. High demand for novel drugs and biotechnology products have further boosted the growth of the market.
Asia pacific region is projected to witness a lucrative growth over the forecast period. This is attributed to the growing pharmaceutical and biotechnology industries that have resulted in significant growth of glycomics in the region. Growing investments in the development of drugs and biologics is anticipated to propel the growth of the market in the region over the forecast period.
Few of the key companies operating in glycobiology market include ProZyme, WATERS, Agilent Technologies, Inc., Bruker, Danaher, New England Biolabs and Thermo Fisher Scientific, Inc. New product launches, partnerships, collaborations, mergers and acquisitions are the key strategies undertaken by these companies for sustainable growth. For instance, in July 2018, Agilent Technologies finalized the acquisition of ULTRA Scientific Assets, that operates in distribution of certified chemical materials and standards. This acquisition was intended to provide the company with life sciences solutions, thereby, creating a wider consumer base.
Glycobiology Market by Product, 2014-2025 (USD Million)
- Mass spectrometers
- Array systems
- Glycan labelling kits
- Glycan purification kits
- Glycan release kits
- Glycosyl transferases
- Sialyl transferases
Glycobiology Market by Application, 2014-2025 (USD Million)
- Drug discovery and development
Glycobiology Market by End-use, 2014-2025 (USD Million)
- Academic and research institutes
- Pharmaceutical and biotechnology companies
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- South Africa
- Saudi Arabia
- Agilent Technologies, Inc.
- New England Biolabs
- Thermo Fisher Scientific, Inc.
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.